NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Airway Stent/Lung Stent Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 921870
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
全球呼吸道支架/肺支架市場:成長,趨勢,及預測(2020年∼2025年) Airway Stent/Lung Stent Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 112 Pages




第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 肺和呼吸系統疾病的患病率增加
    • 對微創手術的偏愛日益增加
  • 市場阻礙因素
    • 替代治療的可用性
    • 支架相關的併發症
  • 波特的五力分析

第5章 市場區隔

  • 各產品
    • 自動擴張型支架
    • 球囊擴張型支架
  • 不同材料
    • 金屬
    • 矽膠
    • 混合
  • 各類型
    • 氣管支氣管支架
    • 咽支架
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Bess AG
    • Boston Scientific Corporation
    • Cook Group
    • E. Benson Hood Laboratories Inc.
    • Efer Endoscopy
    • Endo-Flex GmbH
    • Merit Medical Systems, Inc.
    • Micro-Tech (Nanjing) Co. Ltd.
    • Standard Sci Tech Inc.
    • Taewoong Medical Co. Ltd.

第7章 市場機會及今後趨勢


Product Code: 67340

The airway stent market is believed to witness a healthy growth in the future which is majorly attributed to the rising prevalence of lung and respiratory disorders, and the growing preference of people for minimally invasive surgery.

The American Cancer Society has stated that for the year 2019, about 228,150 new cases of lung cancer are expected to rise in the United States and there would be around 142,670 deaths from lung cancer that the country is expected to witness. Added to that, Chronic obstructive pulmonary disease (COPD) is posing a burden on global healthcare. For instance, the World Health Organization has reported that there were around 251 million cases of COPD globally in 2016. During the year 2016-2017, approximately 3.17 million deaths were caused by COPD. Owing to the rising cases of lung diseases and respiratory disorders, the market for stents used during the surgery of lung or respiratory systems is increasing.

In addition, surgery with the airway or lung stent is minimally invasive surgery. This means there is a lesser hospital stay and there is a minimal pain generated post-surgery. Due to the ease of minimally invasive surgeries, there is a large number of people that are preferring this across the globe which is adding value to the market.

Key Market Trends

Silicon Stents are Expected to Witness Rapid Growth

The silicon stents are proven to be more safe, cost-effective and easy to manipulate when compared to other stents with different materials. The silicon stents come in balloon-expandable and expandable versions. These stents have been very useful in the patients suffering from tracheobronchial strictures both benign and cancer-related. A National Institute of Health has stated that there have been several studies that suggest the efficacy of silicone stents and the successful airway palliation in 85% to 95% cases has been seen from the studies.

Added to that, the silicon stents are also useful in the lung transplantation strictures which makes these stents more significant in terms of preference during the treatment. Owing to its advantages over metallic stents, it is widely being used which is propelling the growth of this segment.

North America Dominates the Market

Being the most developed and advanced region, North America is the world's largest medical device market and airway stents are no exception for the same. Due to the developed healthcare system, the reimbursement scenario for medical devices such as stents is good in the United States. For instance, Medicare Part B covers the majority of stent placement procedures, paying 80 percent of the costs.

In addition, the growing geriatric population and the increasing lung/respiratory disorders in the United States are some of the factors fuelling growth of the market. The presence of large number of companies that manufacture airway/lung stents in the country is again a significant factor that is responsible for the large market size.

Competitive Landscape

The market for airway stents is moderately competitive with the presence of international players as well as few local companies in several countries. However, the major share of the market is grabbed by international players only. The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Lung and Rspiratory Disorders
    • 4.2.2 Growing Preference of People For Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatments
    • 4.3.2 Complications Associated with Stents
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Self-Expandable Stents
    • 5.1.2 Balloon- Expandable Stents
  • 5.2 By Material
    • 5.2.1 Metal
      • Nitinol
      • Stainless Steel
    • 5.2.2 Silicone
    • 5.2.3 Hybrid
  • 5.3 By Type
    • 5.3.1 Tracheobronchial Stents
    • 5.3.2 Laryngeal Stents
  • 5.4 Geography
    • 5.4.1 North America
      • United States
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Bess AG
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cook Group
    • 6.1.4 E. Benson Hood Laboratories Inc.
    • 6.1.5 Efer Endoscopy
    • 6.1.6 Endo-Flex GmbH
    • 6.1.7 Merit Medical Systems, Inc.
    • 6.1.8 Micro-Tech (Nanjing) Co. Ltd.
    • 6.1.9 Standard Sci Tech Inc.
    • 6.1.10 Taewoong Medical Co. Ltd.